Atara Biotherapeutics, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc. for March 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 30 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 14.58 | 1,761 | 25,675 | 172,582 | 174.3 K to 172.6 K (-1.01 %) |
Mar 30 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 14.58 | 2,640 | 38,491 | 135,579 | 138.2 K to 135.6 K (-1.91 %) |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 709 | 8,614 | 12,750 | |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | M | 12.15 | 2,791 | 33,911 | 43,250 | |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 17.41 | 7,000 | 121,870 | 138,219 | 145.2 K to 138.2 K (-4.82 %) |
Mar 15 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Buy | M | 12.15 | 3,500 | 42,525 | 145,219 | 141.7 K to 145.2 K (+2.47 %) |
Mar 04 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Sell | S | 16.74 | 1,665 | 27,872 | 141,719 | 143.4 K to 141.7 K (-1.16 %) |
Mar 04 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Sell | S | 16.74 | 1,461 | 24,457 | 174,343 | 175.8 K to 174.3 K (-0.83 %) |
Mar 04 2021 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Sell | S | 16.74 | 4,887 | 81,808 | 367,621 | 372.5 K to 367.6 K (-1.31 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Option Exercise | A | 17.11 | 81,327 | 1,391,098 | 81,327 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Dupont Jakob | EVP, Head of R&D | Grant | A | 0.00 | 53,879 | 0 | 100,129 | 46.3 K to 100.1 K (+116.50 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Option Exercise | A | 17.11 | 63,028 | 1,078,094 | 63,028 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Murugan Amar | SVP, GC & Secretary | Grant | A | 0.00 | 41,756 | 0 | 97,425 | 55.7 K to 97.4 K (+75.01 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Option Exercise | A | 17.11 | 56,929 | 973,771 | 56,929 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Operations Of ... | Grant | A | 0.00 | 37,715 | 0 | 143,384 | 105.7 K to 143.4 K (+35.69 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Option Exercise | A | 17.11 | 68,314 | 1,168,511 | 68,314 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Koppikar Utpal | Chief Financial Off ... | Grant | A | 0.00 | 45,258 | 0 | 175,804 | 130.5 K to 175.8 K (+34.67 %) |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Option Exercise | A | 17.11 | 176,886 | 3,025,635 | 176,886 | |
Mar 03 2021 | ATRA | Atara Biotherapeut ... | Touchon Pascal | President and CEO | Grant | A | 0.00 | 117,187 | 0 | 372,508 | 255.3 K to 372.5 K (+45.90 %) |